Argent BioPharma Limited (RGTLF)
OTCMKTS · Delayed Price · Currency is USD
0.0900
0.00 (0.00%)
At close: Apr 23, 2025

Argent BioPharma Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Revenue
0.30.893.394.7332.08
Upgrade
Revenue Growth (YoY)
-77.66%-73.69%-28.41%57.94%44.10%216.83%
Upgrade
Cost of Revenue
0.671.22.044.171.91.9
Upgrade
Gross Profit
-0.38-0.31.350.561.10.17
Upgrade
Selling, General & Admin
17.315.5613.3411.837.796.61
Upgrade
Research & Development
1.822.322.99---
Upgrade
Other Operating Expenses
0.32-0.160.224.235.254.85
Upgrade
Operating Expenses
19.4617.7416.5616.0613.0411.46
Upgrade
Operating Income
-19.84-18.04-15.21-15.5-11.94-11.29
Upgrade
Interest Expense
-0.05-0.48-0.26-0.21-0.37-0.14
Upgrade
Interest & Investment Income
00000.010.01
Upgrade
Currency Exchange Gain (Loss)
0.830.83-1.220.08-0.03-0.15
Upgrade
Other Non Operating Income (Expenses)
0.420.060.09-1.24-3.57-2.09
Upgrade
EBT Excluding Unusual Items
-18.63-17.63-16.6-16.86-15.9-13.65
Upgrade
Merger & Restructuring Charges
-1.36-----
Upgrade
Impairment of Goodwill
---3.15-3.9--
Upgrade
Gain (Loss) on Sale of Investments
-1.371.34-1.39---
Upgrade
Gain (Loss) on Sale of Assets
-1.26-1.26----
Upgrade
Asset Writedown
------5.12
Upgrade
Pretax Income
-22.62-17.55-21.13-20.77-15.9-18.77
Upgrade
Income Tax Expense
--0--0.03-
Upgrade
Earnings From Continuing Operations
-22.62-17.55-21.13-20.77-15.87-18.77
Upgrade
Earnings From Discontinued Operations
------0.6
Upgrade
Net Income to Company
-22.62-17.55-21.13-20.77-15.87-19.37
Upgrade
Minority Interest in Earnings
00.020.310.4200.01
Upgrade
Net Income
-22.62-17.53-20.82-20.35-15.87-19.36
Upgrade
Net Income to Common
-22.62-17.53-20.82-20.35-15.87-19.36
Upgrade
Shares Outstanding (Basic)
51373321
Upgrade
Shares Outstanding (Diluted)
51373321
Upgrade
Shares Change (YoY)
284.88%1155.86%14.85%34.63%37.91%14.31%
Upgrade
EPS (Basic)
-0.45-0.47-7.07-7.93-8.33-14.01
Upgrade
EPS (Diluted)
-0.45-0.47-7.10-7.93-8.33-14.03
Upgrade
Free Cash Flow
-11.16-14.8-12.18-14.85-15.32-10.92
Upgrade
Free Cash Flow Per Share
-0.22-0.40-4.13-5.79-8.04-7.90
Upgrade
Gross Margin
-127.08%-34.13%39.88%11.89%36.70%8.40%
Upgrade
Operating Margin
-6705.93%-2024.69%-448.91%-327.54%-398.48%-542.80%
Upgrade
Profit Margin
-7644.88%-1967.34%-614.71%-430.00%-529.70%-931.29%
Upgrade
Free Cash Flow Margin
-3771.39%-1661.19%-359.40%-313.85%-511.23%-525.16%
Upgrade
EBITDA
-18.81-16.97-14.67-15.4-11.6-10.96
Upgrade
D&A For EBITDA
1.031.080.540.10.340.32
Upgrade
EBIT
-19.84-18.04-15.21-15.5-11.94-11.29
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.